{"nctId":"NCT00308737","briefTitle":"Safety of Inhaled Insulin With Type 1 and Type 2 Diabetes","startDateStruct":{"date":"2005-06"},"conditions":["Diabetes, Type 1","Diabetes, Type 2"],"count":2053,"armGroups":[{"label":"TI Inhalation Powder","type":"EXPERIMENTAL","interventionNames":["Drug: Technosphere® Insulin Inhalation Powder"]},{"label":"Usual care","type":"OTHER","interventionNames":["Drug: Usual Care"]},{"label":"Non-diabetes","type":"NO_INTERVENTION","interventionNames":[]}],"interventions":[{"name":"Technosphere® Insulin Inhalation Powder","otherNames":[]},{"name":"Usual Care","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* For All Subjects:\n\n  * Nonsmoking\n  * Body mass index \\<42 kg/m2\n  * FEV1 greater than or equal to 70% of predicted , DLco and TLC greater than or equal to 80% of predicted at screening,\n  * No abnormalities in screening pulmonary radiology\n* For Subjects with diabetes mellitus:\n\n  * Type 1 or type 2 diabetes for at least 2 years\n  * HbA1c greater than or equal to 6.6 % and less than or equal to 12.0 %\n* For Subjects without abnormalities in glucose control:\n\n  * No history of diabetes\n  * Normal results from a formal glucose tolerance test\n\nExclusion Criteria:\n\n* History of chronic obstructive pulmonary disease, asthma, or other significant pulmonary disease\n* Significant renal, hepatic, or cardiac disease\n* Women who are pregnant, lactating, or planning on becoming pregnant\n* Subjects who have participated in studies of other investigational drugs within the previous 3 months\n* Evidence of severe complications of diabetes","healthyVolunteers":true,"sex":"ALL","minimumAge":"18 Years","maximumAge":"70 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Change From Baseline to Month 24 in Forced Expiratory Volume in 1 Second (FEV1) by MMRM for TI vs Usual Care","description":"Change from Baseline to End of Study in FEV1 by MMRM","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.16","spread":"0.208"},{"groupId":"OG001","value":"-0.12","spread":"0.211"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline to Last Measurement in FEV1 for TI vs Usual Care","description":"Change from Baseline to last measurement(Month 24) in FEV1","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.128","spread":null},{"groupId":"OG001","value":"-0.092","spread":null}]}]}]},{"type":"SECONDARY","title":"Change From Baseline to Month 24 in Forced Vital Capacity (FVC) by MMRM","description":"Change from Baseline to Month 24 in FVC by MMRM","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.14","spread":"0.242"},{"groupId":"OG001","value":"-0.11","spread":"0.262"},{"groupId":"OG002","value":"-0.09","spread":"0.210"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline to Month 24 in Total Lung Capacity (TLC) by MMRM","description":"Change from baseline to Month 24 in TLC by MMRM","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.05","spread":"0.321"},{"groupId":"OG001","value":"-0.07","spread":"0.322"},{"groupId":"OG002","value":"-0.02","spread":"0.297"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline to Month 24 in Hemoglobin Corrected DLco by MMRM","description":"Change from baseline to Month 24 in hemoglobin-corrected DLco by MMRM","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.60","spread":"2.830"},{"groupId":"OG001","value":"-1.36","spread":"2.862"},{"groupId":"OG002","value":"-1.33","spread":"3.203"}]}]}]},{"type":"SECONDARY","title":"Forced Vital Capacity (FVC) Decrease of ≥ 15% From Baseline Value at Last Measurement","description":"FVC Decrease of ≥15% from Baseline Value at Last Measurement","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"23","spread":null},{"groupId":"OG001","value":"17","spread":null},{"groupId":"OG002","value":"2","spread":null}]}]}]},{"type":"SECONDARY","title":"Total Lung Capacity (TLC) Decrease of ≥ 15% From Baseline Value at Last Measurement","description":"TLC Decrease of ≥ 15% from Baseline Value at Last Measurement","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"7","spread":null},{"groupId":"OG001","value":"6","spread":null},{"groupId":"OG002","value":"1","spread":null}]}]}]},{"type":"SECONDARY","title":"Hemoglobin-Corrected Diffusing Capacity of the Lung for Carbon Monoxide (DLco) Decrease of ≥ 15% From Baseline Value at Last Measurement","description":"Hemoglobin-corrected DLco decrease of ≥ 15% from baseline value at last measurement","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"105","spread":null},{"groupId":"OG001","value":"108","spread":null},{"groupId":"OG002","value":"20","spread":null}]}]}]},{"type":"SECONDARY","title":"Hemoglobin-Corrected Diffusing Capacity of the Lung for Carbon Monoxide (DLco) Decrease of >3 ml/Min/mmHg From Baseline Value at Last Measurement","description":"Hemoglobin-corrected DLco decrease of \\>3 ml/min/mmHg from baseline value at last measurement","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"181","spread":null},{"groupId":"OG001","value":"181","spread":null},{"groupId":"OG002","value":"40","spread":null}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Glycated Hemoglobin A1c (HbA1c) at Last Measurement for TI vs Usual Care","description":"Change from baseline in HbA1c at last measurement","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.42","spread":"1.410"},{"groupId":"OG001","value":"-0.49","spread":"1.37"}]}]}]},{"type":"SECONDARY","title":"Change in Weight From Baseline at Month 24","description":"Change from baseline in weight at Month 24","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.0","spread":"6.653"},{"groupId":"OG001","value":"1.64","spread":"5.066"},{"groupId":"OG002","value":"1.19","spread":"4.457"}]}]}]},{"type":"PRIMARY","title":"FEV1 Decrease of ≥ 15% From Baseline Value at Last Measurement for TI vs Usual Care","description":"FEV1 decrease of ≥ 15% from Baseline value at last measurement","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"42","spread":null},{"groupId":"OG001","value":"27","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":92,"n":923},"commonTop":["Hypoglycaemia","Cough","Upper respiratory tract infection","Nasopharyngitis"]}}}